{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:59:29Z","timestamp":1791896369417,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801211"],"award-info":[{"award-number":["81801211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.msard.2020.102130","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T21:00:39Z","timestamp":1588107639000},"page":"102130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serum albumin level is associated with the severity of neurological dysfunction of NMOSD patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Xiao-Ying","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7366-0796","authenticated-orcid":false,"given":"Yi-Fan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-9760","authenticated-orcid":false,"given":"Mei-Chun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Hua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Tai","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.msard.2020.102130_bib0001","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bbagen.2013.04.036","article-title":"Redox properties of serum albumin","volume":"1830","author":"Anraku","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.msard.2020.102130_bib0002","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1423-0410.2011.01475.x","article-title":"Immunomodulatory effects of therapeutic preparations of human albumin","volume":"101","author":"Aubin","year":"2011","journal-title":"Vox. Sang."},{"issue":"3","key":"10.1016\/j.msard.2020.102130_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-1281(11)80190-X","article-title":"Immunohistochemical demonstration of interleukin-1 beta induced changes in acute-phase proteins and albumin in rat liver","volume":"97","author":"Ballmer","year":"1995","journal-title":"Acta Histochem."},{"issue":"6","key":"10.1016\/j.msard.2020.102130_bib0004","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/01.CCM.0000217923.53680.4C","article-title":"Commercial human albumin preparations for clinical use are immunosuppressive in vitro","volume":"34","author":"Bar-Or","year":"2006","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.msard.2020.102130_bib0005","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.3390\/ijms131012970","article-title":"Molecular pathogenesis of neuromyelitis optica","volume":"13","author":"Bukhari","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2020.102130_bib0006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/bbrc.1996.0793","article-title":"Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma","volume":"222","author":"Cha","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msard.2020.102130_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-017-0111-x","article-title":"Critical appraisal of the role of serum albumin in cardiovascular disease","volume":"5","author":"Chien","year":"2017","journal-title":"Biomark. Res."},{"issue":"9","key":"10.1016\/j.msard.2020.102130_bib0008","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00415-017-8583-z","article-title":"MOG antibody-related disorders: common features and uncommon presentations","volume":"264","author":"Cobo-Calvo","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2020.102130_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000413163","article-title":"Effect of plasma and interstitial protein content on tissue edema formation","volume":"53","author":"Demling","year":"1986","journal-title":"Curr. Stud. Hematol. Blood Transfus."},{"issue":"2","key":"10.1016\/j.msard.2020.102130_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17512433.2018.1412827","article-title":"Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients","volume":"11","author":"Ferrer","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.msard.2020.102130_bib0011","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2891-9-69","article-title":"Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature","volume":"9","author":"Gupta","year":"2010","journal-title":"Nutr. J."},{"issue":"1","key":"10.1016\/j.msard.2020.102130_bib0012","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.msard.2020.102130_bib0013","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.msard.2020.102130_bib0014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/09680519020080020501","article-title":"Investigation into the interaction of recombinant human serum albumin with Re-lipopolysaccharide and lipid A","volume":"8","author":"J\u00fcrgens","year":"2002","journal-title":"J. Endotoxin. Res."},{"key":"10.1016\/j.msard.2020.102130_bib0015","series-title":"Albumin in Medicine: Pathological and Clinical Applications","first-page":"1","article-title":"Human Serum Albumin: a Multifunctional Protein","author":"Kragh-Hansen","year":"2016"},{"issue":"6","key":"10.1016\/j.msard.2020.102130_bib0016","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1097\/CCM.0b013e318211ff6e","article-title":"Human serum albumin improves endothelial dysfunction and survival during experimental endotoxemia: concentration-dependent properties","volume":"39","author":"Kremer","year":"2011","journal-title":"Crit. Care Med."},{"issue":"9451","key":"10.1016\/j.msard.2020.102130_bib0017","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.msard.2020.102130_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036050","article-title":"Consent for use of clinical leftover biosample: a survey among Chinese patients and the general public","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS ONE"},{"issue":"Pt 4","key":"10.1016\/j.msard.2020.102130_bib0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/000456328201900408","article-title":"Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin","volume":"19","author":"Mikhailidis","year":"1982","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.msard.2020.102130_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.msard.2020.102130_bib0021","series-title":"All About Albumin","article-title":"2 - The Albumin Molecule: its structure and chemical properties","author":"Peters","year":"1995"},{"issue":"3","key":"10.1016\/j.msard.2020.102130_bib0022","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/rns.2011.028","article-title":"Current perspectives on potential role of albumin in neuroprotection","volume":"22","author":"Prajapati","year":"2011","journal-title":"Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.msard.2020.102130_bib0023","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.msard.2020.102130_bib0024","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.msard.2020.102130_bib0025","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.msard.2020.102130_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006618","article-title":"Low serum levels of uric acid and albumin in patients with Guillain-Barre syndrome","volume":"96","author":"Su","year":"2017","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"10.1016\/j.msard.2020.102130_bib0027","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/01.CCM.0000260242.77637.57","article-title":"Albumin resuscitation improves ventricular contractility and myocardial tissue oxygenation in rat endotoxemia","volume":"35","author":"Tokunaga","year":"2007","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.msard.2020.102130_bib0028","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult. Scler."},{"issue":"1","key":"10.1016\/j.msard.2020.102130_bib0029","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/bpa.12097","article-title":"Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications","volume":"24","author":"Uzawa","year":"2014","journal-title":"Brain Pathol."},{"issue":"39","key":"10.1016\/j.msard.2020.102130_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005000","article-title":"Low serum albumin concentrations are associated with disease severity in patients with myasthenia gravis","volume":"95","author":"Weng","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"2","key":"10.1016\/j.msard.2020.102130_bib0031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2020.102130_bib0032","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.msard.2020.102130_bib0033","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102130_bib0034","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cns.12774","article-title":"Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders","volume":"24","author":"Zhang","year":"2018","journal-title":"CNS Neurosci. Ther."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:57Z","timestamp":1761900597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820302066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":34,"alternative-id":["S2211034820302066"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102130","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum albumin level is associated with the severity of neurological dysfunction of NMOSD patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102130"}}